Abstract
IVDs are a backbone of modern state-of-the-art medicine, especially forthcoming precision and personalized medicine; its reliability is of paramount importance for most medical disciplines, including for medical genetic testing, prediction, staging or diagnosis of cancer, or proper microbiological diagnosis. This holds true for individual as well as public health relevant diagnosis and covers both professional and lay use. It is therefore important that the performance of IVDs (both analytical and clinical) is always based on sufficient clinical evidence which can be demonstrated throughout the life cycle of these products (e.g., to address emerging new variants of infectious agents).
Performance evaluation of IVDs must therefore be put high on the agenda of modern regulatory attempts in Europe and globally. The European legislator had to create a well-anchored and sophisticated valid life cycle process for performance evaluation, benchmarking, and even improving the global guidelines of the International Medical Device Regulators Forum (IMDRF). Apart from proper scientific literature search, performance studies of IVDs will be the major source of valid scientific data to underpin the clinical evidence needed for an IVD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Basic UDI-DI:
-
Unique Device Identifier – Device Identifier for identifying manufacturer and IVD model (unit of use)
- CIV-ID:
-
Union-wide unique single identification number for performance studies of IVDs
- CMS:
-
Coordinating Member State
- COM:
-
European Commission
- CS:
-
Common Specification
- DoI:
-
Declaration of Interest by clinical evaluator(s)
- DSG:
-
Device Specific Guidance
- EbM:
-
Evidence-based Medicine
- EN:
-
European Norm
- EUDAMED:
-
European Databank for Medical Devices (and IVDs)
- FDA:
-
Food and Drug Administration, US
- GHTF:
-
Global Harmonisation Task Force
- GSPR:
-
General Safety and Performance Requirements, see IVDR, Annex I
- HTA:
-
Health Technology Assessment
- IB:
-
Investigators Brochure
- IEC:
-
International Electrotechnical Commission, standardization body
- IMDRF:
-
International Medical Device Regulators Forum
- ISO:
-
International Standardization Organization
- IVD:
-
In vitro Diagnostic (medical device)
- IVDR:
-
IVD-Regulation
- MDCG:
-
Medical Device Coordination Group, issues MDCG Guidance
- MDSW:
-
Medical Device Software
- MEDDEV:
-
Medical Device Guideline by COM for the old Directives
- MS:
-
Member State of EU/EEA
- NB:
-
Notified Body, EU conformity assessment body
- PEP:
-
Performance Evaluation Plan
- PER:
-
Performance Evaluation Report
- PMPF:
-
Post Market Performance Follow-up
- PMS:
-
Post Marker Surveillance, by manufacturer
- PSP:
-
Performance Study Plan
- QMS:
-
Quality Management system
- SRN:
-
Single Registration Number (for EUDAMED)
- UDI-DI:
-
Unique Device Identifier – Device Identifier
- URL:
-
Unique Resource Locator (Internet)
References
European Parliament and European Council (2017a) Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. Retrieved from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02017R0746-20220128&from=DE; cited as: IVDR 2017/746
European Parliament and European Council (2017b) Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 concerning medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 9s0/385/EEC and 93/42/EEC. Official Journal of the European Union. L 117, 1-175, cited as: MDR 2017/745. Retrieved from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745
European Parliament and European Council (2014) Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC, cited as CTR 536/2014. Retrieved from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014R0536
Global Harmonization Task Force (2012a) Clinical evidence for IVD medical devices – Key Definitions and Concepts. Retrieved from: https://www.imdrf.org/working-groups/clinical-evidence-ivd-medical-devices
Global Harmonization Task Force (2012b) GHTF/SG5/N8:2012: Clinical evidence for IVD medical devices – clinical performance studies for in vitro diagnostic medical devices. Retrieved from: https://www.imdrf.org/sites/default/files/docs/ghtf/final/sg5/technical-docs/ghtf-sg5-n8-2012-clinical-performance-studies-ivd-medical-devices-121102.pdf
Global Harmonization Task Force (2012c) Global Harmonization Task Force (2012): GHTF SG5 scientific validity determination and performance evaluation. Retrieved from: https://www.imdrf.org/sites/default/files/docs/ghtf/final/sg5/technical-docs/ghtf-sg5-n7-2012-scientific-validity-determination-evaluation-121102.pdf
Medical Device Coordination Group (MDCG) (2022a) MDCG 2022–10: Q&A on the interface between Regulation (EU) 536/2014 on clinical trials for medicinal products for human use (CTR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). Retrieved from: https://ec.europa.eu/health/document/download/59abcc81-fd32-4546-a340-24c8fad4e2ac_en?filename=mdcg_2022-10_en.pdf
Medical Device Coordination Group (MDCG) (2022b) MDCG 2022–9: summary of safety and performance template. Retrieved from: https://ec.europa.eu/health/document/download/b7cf356f-733f-4dce-9800-0933ff73622a_en?filename=mdcg_2022-9_en.pdf
Medical Device Coordination Group (MDCG) (2022c) MDCG 2022–2: guidance on general principles of clinical evidence for In Vitro Diagnostic medical devices (IVDs). Retrieved from:https://ec.europa.eu/health/document/download/f373538f-939c-472f-9536-436b6ddac085_en?filename=mdcg_2022-2_en.pdf
Medical Device Coordination Group (MDCG) (2021): MDCG 2021–21 Rev.1: guidance on performance evaluation of SARS-CoV-2 in vitro diagnostic medical devices. Retrieved from: https://ec.europa.eu/health/document/download/729f09dc-9f95-40b9-a62a-a0e9fff1d252_en?filename=mdcg_2021-21_en.pdf
Medical Device Coordination Group (MDCG) (2020) MDCG 2020–1: guidance on clinical evaluation (MDR)/Performance evaluation (IVDR) of medical device software. Retrieved from: https://ec.europa.eu/health/document/download/19d9e24f-2808-4e00-bfeb-75892047407d_en?filename=md_mdcg_2020_1_guidance_clinic_eva_md_software_en.pdf
Medtech Europe (2021) Clinical evidence requirements for CE certification under the In Vitro Diagnostic Regulation in the European Union, 2nd ed. Nov 2021. Retrieved from: https://www.medtecheurope.org/wp-content/uploads/2020/05/medtech-europe-performance-evaluation-second-edition-1.pdf
International Standardization Organization (ISO) (2019) ISO 20916:2019: in vitro diagnostic medical devices – clinical performance studies using specimens from human subjects – good study practice
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Ecker, W. (2023). Performance Evaluation and Performance Studies of in Vitro Diagnostic Medical Devices Under the IVDR. In: Baumgartner, C., Harer , J., Schröttner, J. (eds) Medical Devices and In Vitro Diagnostics. Reference Series in Biomedical Engineering(). Springer, Cham. https://doi.org/10.1007/978-3-031-22091-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-22091-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-22090-6
Online ISBN: 978-3-031-22091-3
eBook Packages: EngineeringReference Module Computer Science and Engineering